| Identification |
| Name: | 2H-Pyran-2-one,5,6-dihydro-6-[(1E,3R,4R,6R,7Z,9Z,11E)-3,6,13-trihydroxy-3-methyl-4-(phosphonooxy)-1,7,9,11-tridecatetraen-1-yl]-,sodium salt (1:1), (6R)- |
| Synonyms: | 2H-Pyran-2-one,5,6-dihydro-6-[(1E,3R,4R,6R,7Z,9Z,11E)-3,6,13-trihydroxy-3-methyl-4-(phosphonooxy)-1,7,9,11-tridecatetraenyl]-,monosodium salt, (6R)- (9CI); Fostriecin sodium |
| CAS: | 87860-39-7 |
| Molecular Formula: | C19H27 O9 P . Na |
| Molecular Weight: | 452.37 |
| InChI: | InChI=1/C19H27O9P.Na/c1-19(23,12-11-16-9-7-10-18(22)27-16)17(28-29(24,25)26)14-15(21)8-5-3-2-4-6-13-20;/h2-8,10-12,15-17,20-21,23H,9,13-14H2,1H3,(H2,24,25,26);/q;+1/p-1/b3-2-,6-4+,8-5-,12-11+;/t15-,16+,17+,19+;/m0./s1 |
| Molecular Structure: |
 |
| Properties |
| Flash Point: | 400.1°C |
| Boiling Point: | 737.9°C at 760 mmHg |
| Biological Activity: | Originally identified as an antitumor antibiotic from Streptomyces pulveraceous . Displays potent inhibition of protein phosphatase types 2A (PP2A) and 4 (PP4) with IC 50 values of 1.5 nM and 3 nM respectively. Also exhibits weaker inhibition of topoisomerase II (IC 50 = 40 μ M) and protein phosphatase type 1 (PP1) (IC 50 = 131 μ M) with no apparent inhibition of protein phosphatase type 2B (PP2B). Active in vivo . |
| Flash Point: | 400.1°C |
| Storage Temperature: | −20°C |
| Safety Data |
| |
 |
